Answers are grounded in this paper and cite their sources.
Tumor angiogenesis is a process of new blood vessel formation from pre-existing vessels. It is controlled by communications between tumor cells and tumor associated stromal cells with adjacent endothelial cells (ECs). In tumor cells and cancer associated fibroblasts (CAFs) the collagen receptor DDR2 contributes to breast cancer invasion and metastasis. In CAFs, DDR2 influences the secretion of growth factor such as the pro-angiogenic VEGF. As such, DDR2 has been suggested to contribute to tumor angiogenesis, but whether through EC-intrinsic actions or via factors secreted by tumor cells or CAFs has not been established. Human breast tumor scRNAseq data and multiplex immunohistochemistry (mIHC) analyses revealed that a subset of tumor ECs, perhaps migratory tip-like cells, and lymphatic endothelial cells (LECs) express DDR2, particularly in metastatic TNBC tumors. To determine if DDR2 played an endothelial cell-intrinsic role in breast tumor angiogenesis and metastasis, we selectively deleted Ddr2 in ECs using the inducible Cdh5-CreERT2 allele in the context of the MMTV-PyMT metastatic mouse breast tumor model. This resulted in decreased lung metastases without any change in primary tumor burden or total tumor ECs. There were, however, significant alterations in endothelial vessel length in primary tumors. Ddr2-deleted mice also exhibited defects in normal angiogenesis. Using 3D microfluidic devices, primary cells, and aortic ring outgrowth assays genetic depletion and chemical inhibition of Ddr2 resulted in reduced EC migration and decreased tip cell like gene expression. Together, these data define a role of EC DDR2 in normal and breast tumor angiogenesis that could contribute to metastasis.
No takes yet. Share an insight, caveat, or question.
DiMauro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: